Raised Intracranial Pressure
Download
Report
Transcript Raised Intracranial Pressure
RAISED INTRACRANIAL
PRESSURE
03/05/12
Jeremy Kam
Intern
Royal Melbourne Hospital
OVERVIEW AND OBJECTIVES
Basic Principles
Review Basic Anatomy of Skull and Spinal Cord
Review Basic Physiology of CSF production and flow
Monro Kellie Doctrine and concepts of CBF and CPP
Conceptualising ICP
Spectrum of Intracranial Pressure
Causes of Raised ICP
Assessment of Raised ICP
Symptoms
Signs and basic examination techniques
Investigating ICP
Management
Monitoring
Treatment
CONTENTS OF THE SKULL AND
THE MONRO KELLIE DOCTRINE
1 . Skull is a rigid box: The volume inside the cranium is a fixed
volume (nearly).
2. The cranial contents incompressible (nearly)
3. The cranium and its constituents (blood, CSF, and brain tissue)
create a state of volume equilibrium, such that any increase in
volume of one of the cranial constituents must be compensated by
a decrease in volume of another
FIXED BOX: SKULL/SPACE
1. BRAIN
2. CSF
3. BLOOD
INTRACRANIAL VOLUME
INTRACRANIAL PRESSURE
“Intracranial pressure (ICP) is the pressure
inside the skull and thus in the brain tissue and
cerebrospinal fluid (CSF).”
Constantly changing: exercise, coughing, straining,
respiratory cycle
ICP normal values
Age Group
Normal Range
(mmHg)
Adults and older
children
< 10-15
Young Children
3-7
Term Infants
1.5-6
Standing
0
INTRACRANIAL PRESSURE VS
INTRACRANIAL VOLUME
INTRACRANIAL PRESSURE VS
INTRACRANIAL VOLUME
CEREBRAL PERFUSION PRESSURE
CPP = MAP – ICP
CEREBRAL PERFUSION PRESSURE = MEAN ARTERIAL PRESSURE –
INTRACRANIAL PRESSURE
Why do we care?
1. Brain survival depends on cerebral blood flow meeting cerebral
metabolic requirements
2. Cerebral blood flow depends on Cerebral Perfusion Pressure
3. CPP depends upon ICP
Normal CPP > 50 mmHg
CEREBRAL BLOOD FLOW
INTRACRANIAL HYPERTENSION (FINALLY)
What happens if ICP is too high?
CPP = MAP – ICP
As ICP increases. Where MAP is constant. CPP will decrease.
Ideally CPP > 70-80mmHg
This is bad.
IC-HTN = ICP >20mmHg for >10 minutes
Increased ICP Decreased CPP Decreased CBF
MAP will compensate for awhile.
CBF = CPP/CVR
INTRACRANIAL HYPERTENSION
Why do we care?
Raised ICP may CAUSE problems itself e.g herniation,
decrease in cerebral perfusion ischemia edema
Raised ICP may be a SIGN of problems being caused e.g mass
ef fect; tumour, haemorrhage
CAUSES OF RAISED ICP
SPECTRUM OF RAISED ICP
ACUTE VS CHRONIC
SEVERE VS MILD
SYMPTOMS AND SIGNS from raised ICP
SYMPTOMS AND SIGNS from CAUSE of raised ICP
E.g:
Acute Traumatic Intracranial Haemhorrhage Mass Ef fect
Vs
Neoplasm causing Mass ef fect
CAUSES OF RAISED ICP
INTRACRANIAL HAEMHORRAGES
Subdural
Hematoma
Epidural
Hematoma
Intracerebral
Haemorrhage
Subarachnoid
Haemorrhage
Cerebral
Contusion
SPACE OCCUPYING LESION
Brain Abscess:
Develop as a result of a localized
bacterial cerebritis followed by
necrosis and encapsulation
Mechanisms:
– Haematogenous
– Extension from neighbouring
structures
– Penetrating injuries
Symptoms of infection may be
absent in 50% of cases
Treatment: Excision drainage
HYDROCEPHALUS
1 O b s t r uc t iv e hy d ro c eph a lus – o b s t r uc t io n
f r o m l e s i o n a l o n g v e n t r i c l e s y s te m . E . g t u m o r,
c o l l o id c y s t , p r i m a r y s te n o s i s .
2 C o m m un i c a t in g hy d ro c e p h a l us - ( a )
o b s t r uct i o n to f l o w o f C S F t h r o ug h t h e b a s a l
c i s te r n s o r ( b ) f a i l ur e o f a b s o r p t i o n o f C S F
t h r o ug h t h e a r a c h n o i d g r a n u l a t i o n s o v e r t h e
c e r e b r al h e m i s p h e r e s . T h e m o s t c o m m o n
c a u s e s o f c o m m un i ca t i n g hy d r o ce p h a l us a r e
i n f e c t i o n ( e s p e c i a l l y b a c te r ia l a n d
t u b e rc ul o us ) a n d s u b a r a c h n o id h a e m o r rh a g e
( e i t h e r s p o n t a n e o us , t r a um a t i c o r
p o s to p e r a t i v e ).
Tr e a t m e n t : Ve n t r i c ul o p e r ito n e a l S h u n t ,
3 r d Ve n t r i c ul o s to my
TRAUMATIC BRAIN INJURY
CEREBRAL OEDEMA
Middle cerebral artery
occlusion causing
extensive infarction with
mass effect. The
appearances after
decompressive
craniotomy are shown in
the third panel.
SYMPTOMS AND SIGNS
1 . Decreased LEVEL OF CONSCIOUSNESS - DROWSINESS
MOST IMPORTANT
never put down to simple sleepiness – measure Glasgow Coma Scale
Requires serial assessment Progressive decrease in GCS = worsening ICP state
2. Altered MENTAL STATUS
Confusion, restlessness, lethargy, difficulty thinking,
3. HEADACHE
Frontal, worse after lying down, Relieved by vomiting, Severe, Worse with coughing
and straining
4. NAUSEA and VOMITING
Persistent
5. VISUAL CHANGES
Pupillary Dysfunction
Changes in Vision
VI nerve Palsy – false localising sign
Papilloedema - requires more than 24 hours
GLASGOW COMA SCALE
ABDUCENS PALSY
PAPILLOEDEMA
Ve n o u s e n g o r g em e n t ( u s u a l l y t h e f i r s t s i g n s )
loss of venous pulsation
h e m o r rh a g e s o v e r a n d / o r a d j a c e n t to t h e o p t i c d i s c
b l u r r in g o f o p t i c m a r g i n s
e l ev a t i o n o f o p t i c d i s c
P a to n ' s l i n e s = r a d i a l r et i n a l l i n e s c a s c a d i n g f r o m t h e o p t i c d i s c
PROGRESSION OF SIGNS
Continuous
to a r o u s e
DECREASE in GCS
s t u p o r o u s c o m a to s e d i f f i c u l t y
VISUAL CHANGES
P u p i l s b e c o m e u n i l a t e r a l l y e n l a r g e d p r o g r e s s i n g to fi x e d a n d d i l a te d – e v e n t u a l l y
b i l a te r a l l y fi x e d a n d d i l a te d
Papilloedema
NEUROLOGICAL F UNCTION
D e c o r t i c a t e o r D e c e r e b r a t e Po s t u r i n g
L o s s o f c o r n e a l a n d g a g r e fl e x e s
Hemiplegia –that progresses
VITAL SIGNS
B r a d yc a r d i a
I n c r e a s i n g H y p e r te n s i o n – w i t h w i d e n i n g p u l s e p r e s s u r e
I r r e g u l a r Re s p i r a t i o n – n e u r o g e n i c H y p e r v e n t i l a t i o n
Re s p i r a t o r y a r r e s t
C u s h i n g ' s Tr i a d
Hyperthermia
S I G N S O F B R A I N H E R N IAT I ON
CUSHING’S TRIAD
seen in 33% of IC-HTN
1. HYPERTENSION (Widening Pulse Pressure)
2. BRADYCARDIA
3. RESPIRATORY IRREGULARITY
INDICATES IMPENDING HERNIATION
BRAIN HERNIATION SYNDROMES
Transtentorial:
Foramen Magnum
Subfalcine
SEVERIT Y AND INDICATIONS
Indications for Treatment:
ICP ≥ 20- 25 mmHg as the upper limit. Initiate Treatment for ICP > 20 mmHg –
in combination with clinical exam and brain CT findings.
Herniation can still occur at ICP < 20
Higher mortality and worse outcomes among patients with ICP persistently >20
compared to < 20.
CPP Targets:
Avoid CPP < 50mmHg
Initiate treatment when CPP falls below 60mmHg
INVESTIGATIONS
LUMBAR PUNCTURE IS
CONTRAINDICATED
CT Brain
MRI Brain
Biopsy
Angiography
Transcranial Doppler Flow Velocity
MANAGEMENT - MONITORING
Indications for ICP Monitoring:
CT CRITERIA:
For salvageable patients with severe traumatic brain injury – GCS ≤ 8 after
cardiopulmonary resuscitation
Abnormal admitting brain CT (60% risk of IC -HTN)
or
Normal brain CT but with ≥2 risk factors (=60% risk of IC –HTN vs 13% r.f -ve):
• Age >40 years
• SBP < 90 mmHg
• Decerebrate or decorticate posturing on motor exam – unilateral or bilateral
Neurological criteria – where GCS ≥ 9 – low risk for IC -HTN – serial
neurological exam
M ultiple system injur y – where ICP likely to be ef fected by inter ventions
e.g large volume IV fluids, PEEP
Traumatic IC M ass – EDH, SDH, depressed skull fracture
Post Op – may elect
Non -traumatic
Contraindications to ICP monitoring: “awake” patient, coagulopathy
INVASIVE ICP MONITORING
Intraventricular Catheter – IVC
Most accurate, allows therapeutic CSF drainage
May be difficult to insert into compressed or displaced ventricles, may
obstruct
Intraparenchymal monitor
Subarachnoid Screw (bolt)
MANAGEMENT
1 . MAINTAIN CEREBRAL PERFUSION PRESSURE by LOWERING ICP
Re duc e s i z e o f bra i n VOLUM E by de c re a sing c e re bra l vo lume , CSF fl ui d vo l ume,
o r bl o o d vo lume w h i l e m a in t aining c e re bra l pe r fus i on
M a ke m o re S PACE – e . g s urg i c al de c o m pression
G OAL ICP < 2 0 m m H g a n d CP P > 5 0 m m H g
2.DECREASE METABOLIC DEMANDS
3. PREVENT COMPLICATIONS
GI risk of developing C ushing stress ulcers and GI bleeding. Give PPIs and H2 antag.
F l u i d a n d e l e c t r o l y t e s – d i a b e t e s i n s p i d u s - d e s m o p r e s s i n . C l o s e m o n i to r i n g o f
electrolytes.
H e m a to l o g i c a l – D I C c a n o c c u r a f te r s e v e r e h e a d i n j u r y. C o a g u l o p a t h i e s a g g r e s s i v e l y
t r e a te d F F P a n d V i t K 10 m g a d a i l y.
Nutrition
4. IDENTIFY CAUSE – TREAT
e . g re m ove s pa c e o c c upy i n g l e sions, i n ser t V P s h un t
BLOOD VOLUME
↓ ICP via ↑ Venous Outflow
Elevation of Head of Bed 30-45 degrees
optimised trade of f between promoting Venous Outflow vs
Reducing MAP
Keep Neck Straight Midline ,
tape
av o i d t i g h t t r a c h
Maintain CPP with Normotension
Av o i d H y p ote n s i o n ( S B P < 9 0 m m H g ) A c h i eve d v i a
n o r m al i s i n g i n t r ava s c ula r v o l ume . U s e o f p r e s s o r s i f
needed.
C o n t r o l hy p e r te n s i o n i f p r e s e n t , N i t ro p r us s i d e i f n i l t a c hy
v s b et a b l o c ke r i f t a c hy
Hyper ventilation
M ay b e n e c e s s a r y f o r b r i e f p e r i o d s w h e n a c u te n e u r o l o g ic
d ete r i o r a t i o n . D o n o t u s e p r o p hy l ac t i c al l y. S h o r t te r m .
Ve ntilate to N O R M O c a r bi a PaCO 2 = 3 5 -4 0 mmHg)
Avoid H y p ox i a (PaO 2 < 6 0 mmHg or sat 9 0 %) – maintain air way and
oxyge nation ↓ O 2 = bad
BRAIN VOLUME
OSMOTIC AGENTS
Mannitol - Ef fects occur within 20 minutes; does not cross intact blood brain barrier; obser ve for rebound ICP; 0.25-1 gm/k g IV over 24h
Frusemide 10-20mg IV q6 hour s. PRN ICP > 20.
Hyper tonic Saline - When refractor y to mannitol – 3% saline infusion or
bolus – if serum osmolarity greater than 320 – hold no more benefit
EUVOLEMIA
CORTICOSTEROIDS
Decreases cerebral edema in brain tumor s
Reduce CSF producti on, stabilize blood -brain barrier and cell membranes > overall improvement of neuronal function
Dexamethasone
CSF VOLUME
Drain CSF
Ventriculostomy – Pliable catheter inser ted into lateral ventricle on
nondominant side
Can remove CSF intermittently or continuously
Removal of even small amount will dramatically decrease ICP
Shunts
DECREASING METABOLIC DEMAND
TEMPERATURE CONTROL
Antipyretic medications, cooling blanket
SEIZURE CONTROL
Phenytoin: 15-18 mg/kg; not to exceed 50 mg/min
Diazepam: 5-10 mg bolus at 2 mg/min
Barbiturates (Pentobarbital & thiopental) when not responsive to
conventional therapy
SEDATION
Paralyzing agents; CV monitoring; endotracheal intubation; mechanical
ventilation; ICP monitoring; arterial pressure monitoring
Reduce sympathetic tone
ENVIRONMENT
dark room – free from noise minimise stimulus.
SURGICAL MANAGEMENT
Decompressive Craniectomy
Considered for IC-HTN refractory to medical treatment.
Surgical Mx of subdural, epidural or intraparenchymal
hematoma.